Loss of ROR2 Tyrosine Kinase Receptor Is Associated With Endothelial Dysfunction in PAH via Inappropriate Integrin β1 Activation.
Background Endothelial dysfunction is a key feature of pulmonary arterial hypertension (PAH). Previously, we demonstrated decreased Wnt7a transcript levels, causing reduced angiogenesis in PAH. Wnt7a expression correlates with tip formation via ROR2 (receptor tyrosine kinase-like orphan receptor 2), a tyrosine kinase receptor. We hypothesized that ROR2 activation in pulmonary microvascular endothelial cells (PMVECs) promotes angiogenesis, particularly endothelial barrier establishment, and its loss causes PAH.Methods Endothelial-specific ROR2 knockout (ROR2 ECKO) and wild-type mice were studied under normoxia and chronic hypoxia using echocardiography, hemodynamics, and lung morphometry. PMVECs from healthy and PAH lungs were transfected with ROR2 siRNA/constructs for functional and molecular studies. Focal adhesion activation and force generation were assessed via Förster resonance energy transfer-based methods. Bulk and single-cell transcriptomic analyses were performed on siROR2 (ROR2 siRNA) PMVECs and ROR2 ECKO lungs.Results ROR2 ECKO mice exacerbated pulmonary hypertension and vascular remodeling in hypoxia. Single-cell RNA-sequencing of lung endothelial cells revealed dysregulated barrier formation and angiogenesis. Evans blue dye extravasation confirmed reduced endothelial barrier integrity in ROR2 ECKO mice. ROR2-deficient PAH PMVECs displayed increased adhesion, permeability, and focal adhesion numbers, with reduced VE-cadherin at cell junctions. Confocal imaging and foster resonance energy transfer revealed ROR2 localization in focal adhesions, interacting with ITGB1 (integrin β1) which remained in an active, adhesion-promoting state in ROR2-deficient cells. Restoring ROR2 in PAH PMVECs normalized adhesion, barrier function, and focal adhesion abundance. Transcriptomic analysis revealed Rab12 mediated ROR2-ITGB1 crosstalk, whose knockdown mimicked ROR2 deficiency in PMVECs.Conclusions ROR2 regulates pulmonary angiogenesis by maintaining endothelial barrier integrity and facilitating integrin recycling. ROR2 restoration could be a potential therapeutic approach for PAH.
Authors
- Ananya Chakraborty (ORCID: https://orcid.org/0000-0003-0974-6370)
- Ryan D. Leib (ORCID: https://orcid.org/0000-0002-8129-1916)
- Kwan Man (ORCID: https://orcid.org/0000-0001-5663-6866)
- Eleana Stephanie Guardado
- Prakash Chelladurai (ORCID: https://orcid.org/0000-0002-8258-5115)
- Amanda Pacheco (ORCID: https://orcid.org/0000-0001-7108-2128)
- Natasha Auer (ORCID: https://orcid.org/0000-0002-5573-0356)
- Alexander R. Dunn (ORCID: https://orcid.org/0000-0001-6096-4600)
- Brian L. Zhong (ORCID: https://orcid.org/0000-0001-8818-5692)
- Olivier T. Guenat (ORCID: https://orcid.org/0000-0003-1103-9712)
- Lyong Heo (ORCID: https://orcid.org/0000-0003-4158-9600)
- Wolfgang M. Kuebler
- Zhiyu Dai (ORCID: https://orcid.org/0000-0002-0821-2839)
- Jason Hong
- Anuradha Bankar
- Stuti Agarwal
- Ananya Jain
- Dan Yi
- Ramesh Nair
- Juan Andrés Matos Muñoz
- Vinicio A de Jesus Perez
- Arpita Roy
- Hanqiu Zhao
Institutions
- Organ Technologies (Japan) (JP)
Publication Details
- Journal
- Open Access CRIS of the University of Bern
- Published
- 2026-02-04
- DOI
- https://doi.org/10.48620/94444
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00